ShiraTronics' Latest Pilot Study Shows Promising Neuromodulation Therapy for Chronic Migraine Success ShiraTronics has revealed positive 12-month follow-up results from its RELIEV-CM study, highlighting sustained benefits in chronic migraine treatment with an investigational device.

ShiraTronics' Latest Pilot Study Shows Promising Neuromodulation Therapy for Chronic Migraine Success #USA #Minneapolis #ShiraTronics #Migraine_Therapy #RELIEV-CM

ShiraTronics Launches Pivotal Study for Neuromodulation Treatment to Alleviate Chronic Migraines ShiraTronics has begun pivotal study of its implantable neuromodulation therapy for chronic migraines in patients across the U.S. and Australia.

ShiraTronics Launches Pivotal Study for Neuromodulation Treatment to Alleviate Chronic Migraines #USA #Minneapolis #Chronic_Migraine #ShiraTronics #Neuromodulation